BELGIUM – Bone Therapeutics has provided data update for its ongoing clinical studies on enhanced viscosupplement, JTA-004, targeting osteoarthritic knee pain. The JTA-004 Phase III clinical study, having achieved target…
Read MoreTag: Bone Therapeutics
Bone Therapeutics secures loan worth €16m from the European Investment Bank
BELGIUM – Bone therapeutics, a cell therapy company that focuses on orthopedic treatment, has signed a loan agreement worth €16m with European Investment Bank (EIB) to bolster its ongoing development…
Read More